[Survival analysis of early-onset locally advanced rectal cancer: a retrospective study based on the Surveillance, Epidemiology, and End Results (SEER) database].

Zhonghua Wei Chang Wai Ke Za Zhi

Department of Colorectal Surgery, National Cancer Center, National Cancer Clinical Medical Research Center, Cancer Hospital of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021,China.

Published: January 2023

To investigate the factors influencing tumor-specific survival of early-onset locally advanced rectal cancer. All-age patients with primary locally advanced rectal cancer from the Surveillance, Epidemiology, and End Results (SEER) database (2010 to 2019) were included in this study. Early- and late-onset locally advanced rectal cancer was defined according to age of 50 years at diagnosis. Early-onset locally advanced rectal cancer was divided into five age groups for subgroup analyses. Age, sex, tumor-specific survival time and survival status of patients at diagnosis, pathological grade, TNM stage, perineural invasion, tumor deposits, tumor size, pretreatment CEA , radiotherapy, chemotherapy, and number of lymph node dissections were included. Progression-free survival (PFS) was analyzed and compared between patients with early- and late-onset rectal cancer. A total of 5,048 patients with locally advanced rectal cancer were included in the study (aged 27-70 years): 1,290 (25.55%) patients with early-onset rectal cancer and 3,758 (74.45%) patients with late-onset rectal cancer. Patients with early-onset rectal cancer had a higher rate of perineural invasion (<0.001), more positive lymph nodes dissected (<0.001), higher positive lymph node ratios (<0.001), and a higher proportion receiving preoperative radiotherapy (=0.002). Patients with early-onset rectal cancer had slightly better short-term survival than those with late-onset rectal cancer (median (IQR ): 54 (33-83) vs 50 (31-79) months, χ=5.192, =0.023). Multivariate Cox regression for all patients with locally advanced rectal cancer showed that age (=0.008), grade of tumor differentiation (=0.002), pretreatment CEA (=0.008), perineural invasion (=0.021), positive number (=0.004) and positive ratio (=0.001) of dissected lymph nodes, and sequence of surgery and radiotherapy (=0.005) influenced PFS. This suggests that the Cox regression results for all patients may not be applicable to patients with early-onset cancer. Cox analysis showed tumor differentiation grade (patients with low differentiation had a higher risk of death, =0.027), TNM stage (stage III patients had a higher risk of death, =0.025), T stage (higher risk of death in stage T4, <0.001), pretreatment CEA (=0.002), perineural invasion (<0.001), tumor deposits (=0.005), number of dissected lymph nodes (patients with removal of 12-20 lymph nodes had a lower risk of death, <0.001), and positive number of dissected lymph nodes (<0.001) were independent factors influencing PFS of patients with early-onset locally advanced rectal cancer. Patients with early-onset locally advanced rectal cancer were more likely to have adverse prognostic factors, but an adequate number of lymph node dissections (12-20) resulted in better survival outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.cn441530-20220704-00291DOI Listing

Publication Analysis

Top Keywords

rectal cancer
40
locally advanced
24
advanced rectal
24
early-onset locally
12
rectal
10
cancer
10
surveillance epidemiology
8
epidemiology seer
8
tumor-specific survival
8
included study
8

Similar Publications

Background: Patients with rectal cancer (RC) are at risk of developing cancer-related cachexia, a complex metabolic syndrome that can negatively impact quality of life (QoL), treatment tolerance, and clinical response.

Objectives: The aim of the study was to explore the possible associations of the novel European Organization for Research and Treatment of Cancer QoL Questionnaire-Cancer Cachexia (EORTC QLQ-CAX24) scores with body composition parameters and physical performance in patients with locally advanced RC (LARC).

Methods: This prospective observational study involved RC patients evaluated at the dedicated outpatient clinic of Clinical Nutrition at the Fondazione Policlinico Agostino Gemelli IRCCS.

View Article and Find Full Text PDF

There is no reliable immune scoring system that can help us predict the postoperative outcomes of colorectal cancer patients with peritoneal metastases after cytoreductive surgery. In this cohort, the aims were (1) to evaluate the postoperative morbidity, mortality and surgical oncological outcomes in colorectal cancer patients with peritoneal metastasis; (2) to compare oncological and postoperative outcomes of colon cancer patients with peritoneal metastasis and rectal cancer patients with peritoneal metastasis; and (3) to assess the prognostic value of the modified Glasgow Prognostic Score (mGPS) and the CRP-albumin ratio (CAR). : A prospectively maintained database of 258 patients who underwent cytoreductive surgery for peritoneal metastases of colorectal origin between 2007 and 2024 was analyzed.

View Article and Find Full Text PDF

Colorectal Cancer: A Brief and Simplified Analysis of a Complex Disease.

Medicina (Kaunas)

December 2024

Department of Medical Genetics, Faculty of Pharmacy, Medical University, 5800 Pleven, Bulgaria.

This study examined factors influencing the onset and progression of colorectal tumors, including patients' epidemiological data, tumor location (right-sided, left-sided, and rectal), histomorphology, perineural or intraneural invasion, lymph node status, immune reactions, mismatch repair (MMR) status, and commonly observed mutations. Our primary goal was to evaluate their predictive and prognostic value and interactions. We analyzed a retrospective cohort of 100 patients with colorectal adenocarcinoma diagnosed between 2020 and 2023, using formalin-fixed paraffin-embedded (FFPE) tumor blocks.

View Article and Find Full Text PDF

: Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and is the third leading cause of cancer-related deaths. In 2020 alone, there were over 1.9 million new cases of CRC and nearly 0.

View Article and Find Full Text PDF

Primary Prostatic Stromal Sarcoma: A Case Report and Review of the Literature.

Medicina (Kaunas)

November 2024

Division of Medical Oncology, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara 06620, Türkiye.

: Primary prostatic stromal sarcoma is an exceptionally rare urological malignancy, constituting less than 0.1% of all prostatic cancers. It poses a significant clinical challenge due to its aggressive behavior and poor prognosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!